Tracer library / [68Ga]TacsBOMB3

[68Ga]TacsBOMB3

Also written as [Ga-68]Ga-TacsBOMB3

Radionuclide: Ga-68 t½ 67.71 min
Modality: PET
Production route: —
Stage: Preclinical
Syntheses indexed: 0

Preclinical only, no clinical indication yet

What it is

Compound class: GRPR-targeting bombesin(7-14) peptide antagonist derivative
Target / mechanism: Gastrin-releasing peptide receptor (GRPR) antagonist PMID 35744904
Clinical application: PET imaging of GRPR-expressing solid tumors (e.g., prostate cancer xenografts) PMID 35744904
Theranostic pair: —

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [68Ga]TacsBOMB3, or handle the enquiry for you.

Get in touch

Notes

Added at stage 22: promoted from 'Reported once' (single-article, no diagnostic pair at discovery) because a full-text synthesis with extracted data exists in parsed-therapy.xlsx -- PMID(s): 35744904. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Compound class inferred from precursor name (not stated outright) -- PMID 35744904: 'TacsBOMB2, TacsBOMB3, TacsBOMB4, TacsBOMB5, and TacsBOMB6'. | Stage 30 (2026-09-18): Modality was 'Therapy' -- a bucket value given to every agent found by the therapy-oriented bulk search (stages 21-22), not a source statement. Corrected to PET: Ga-68 is a positron emitter used only for PET imaging. Linked articles: PMID 35744904. Stage set/updated at stage 39 from PMID 35744904: '[68Ga]Ga-TacsBOMB2, [68Ga]Ga-TacsBOMB3, [68Ga]Ga-TacsBOMB5, [68Ga]Ga-TacsBOMB6, and [68Ga]Ga-RM2 clearly show PC-3 tumor xenografts in positron emission tomography (PET) images'.